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Abstract
RNA expression data reveals that human embryonic stem (hES) cells differ from mouse ES (mES) cells in the expression of
RNAs for keratin intermediate filament proteins. These differences were confirmed at the cellular and protein level and may
reflect a fundamental difference in the epithelial nature of embryonic stem cells derived from mouse and human
blastocysts. Mouse ES cells express very low levels of the simple epithelial keratins K8, K18 and K19. By contrast hES cells
express moderate levels of the RNAs for these intermediate filament proteins as do mouse stem cells derived from the
mouse epiblast. Expression of K8 and K18 RNAs are correlated with increased c-Jun RNA expression in both mouse and
human ES cell cultures. However, decreasing K8 and K18 expression associated with differentiation to neuronal progenitor
cells is correlated with increasing expression of the Snai2 (Slug) transcriptional repression and not decreased Jun expression.
Increasing K7 expression is correlated with increased CDX2 and decreased Oct4 RNA expression associated with the
formation of trophoblast derivatives by hES cells. Our study supports the view that hES cells are more similar to mouse
epiblast cells than mouse ES cells and is consistent with the epithelial nature of hES cells. Keratin intermediate filament
expression in hES cells may modulate sensitivity to death receptor mediated apoptosis and stress.
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Introduction
Keratin intermediate filament proteins, keratin 8 (K8, Krt8,
EndoA) and keratin 18 (K18, Krt18, EndoB) were first identified
in liver and as markers of mouse embryonal carcinoma (EC) and
embryonic stem (ES) cell differentiation [1–3]. Investigation of
early mouse embryos confirmed that the differentiation of the
inner cell mass of mouse blastocysts to trophoblast derivatives and
extra-embryonic endoderm parallels the induction and accumu-
lation of K8 and K18 [4–6]. The mouse inner cell mass initially
expresses low amounts of K8/K18 intermediate filaments but then
represses expression [7,8]. Many studies have confirmed the low
levels of both protein and RNA for K8 and K18 in mouse ES cells
in their undifferentiated state. The isolation of human ES cells that
express transcription factors associated with pluripotentiality in
mouse ES cells (Oct4, Sox2, Nanog) led to the expectation that
epithelial keratins K8 and K18 might be expressed at similar low
levels as mES. [9]. Recently a new pluripotent stem cell, the
epiblast stem cell (EpiSC), derived from post-implantation mouse
embryos was isolated and characterized by two different
laboratories [10,11]. While ES cells and EpiSC cells share
characteristics of pluripotency such as the expression of Oct4,
Sox2 and Nanog, the gene expression profile of EpiSC includes
markers of the embryonic epiblast and resembles human ES cells
more than mouse ES cells. Our analysis of the published RNA
expression profiles of hES, mES and EpiSC reveals that K8 and
K18 RNAs are greatly elevated in EpiSC.
Here we show that expression of K8, K18 and K19 is
characteristic of hES cell lines in the undifferentiated state and
contrasts with mES cells but is similar to EpiSC. The
differentiation of hES to neuronal progenitors results in decreased
expression of these keratins and elevated expression of neuronal
markers while the spontaneous differentiation of hES cells to
presumptive extraembryonic endodermal derivatives results in
increased accumulation of K18. Expression of K8, K18 and K19
are characteristic of the epithelial nature of undifferentiated hES
cells and contrasts with mouse ES cells.
Results
Differential expression of keratin RNA in human and
mouse ES cells
The RNAs for simple epithelial keratins K8, K19 and K19 are
expressed at low levels in undifferentiated mES and embryonal
carcinoma (EC) cells [2,3]. Figure 1A shows a typical time course
of induction of K8, K18 and K19 RNAs as measured by cDNA
array analysis, during the differentiation of mES cells as embryoid
bodies. The baseline expression of these genes in undifferentiated
ES cultures varies with the extent of contamination from
spontaneously differentiated cells. In contrast to mES cells,
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of K8 (34 fold), K18 (26 fold) and to a less extent K19 (6 fold) while
the pluripotency factors Nanog, Sox2 and Oct4 (Pou5f1) vary little
between the two different cell type (Figure 1B). The expression of
K8 and K18 RNAs appear coordinately regulated (Figure 1C).
Furthermore the increased expression of K8 and K18 RNA in
EpiSC is directly correlated with increased expression of Jun
(Figure 1D), a component of AP1 transcription factor activity and
previously identified as a key regulatory of K18 gene regulation
[12,13,14,15]. We suggest that epithelial keratin gene expression is
consistent with the definitive polarized epithelial nature of the
mouse epiblast.
In contrast to mES cells, publicly available data show that hES
cells and human embryonal carcinoma cells express significant
levels of K8, K18 and K19 RNAs [9,16–18]. One example is
shown in Figure 2A in which keratin RNA expression of
undifferentiated hES cells is compared to cells grown as embryoid
bodies. K8 and K18 RNAs are easily detected in hES lines and is
modestly increased during embryoid body differentiation. These
data are supported by a meta analysis of 38 different array
experiments. [19] (http://amazonia.montp.inserm.fr/). While K8
and K18 are expressed in hES cells, differentiation of the cells
commonly results in higher expression and thus resulted in the
identification of K8, K18 and K19 as under expressed in hES cells
compared to differentiated cell types.
Examination of the data of individual array experiments
revealed that K8 and K18 levels are very tightly correlated
(Figure 2B). K19 RNA is also correlated with K8 levels (Figure 2C).
In addition, like mES and mEpiSC cells, K18 RNA expression is
associated with increased Jun RNA expression (Figure 2D). One
quantitative difference between hES and mEpiSC is the relative
expression level of K19, which is as strong as K18 in hES cells.
While comparison of hES and mEpiSC and mES cells depends on
similar sensitivities of measuring K19 and K19 RNAs, western blot
analysis of the proteins support the view that hES cells may have
greater relative contribution from K19 than mES or mEpiSC cells.
K19 is highly expressed in hES cells
To confirm expression of K8 and K18 in hES cells, we
performed western blot analysis with antibodies that recognized
both mouse and human forms of K8, K18 and K19. Typical
results for K8 and K18 are shown in Figure 3. Human ES cells
express moderate levels of K8 and K18 proteins (Figure 3B, lanes
5,6) compared to mouse parietal endodermal cells (Figure 3A, B,
lane 3). Mouse ES cells express very low levels of the two keratin
proteins (Figure 3A, B, lane 4) as expected from the low RNA
levels. Human ES cells also express significant levels of K19
(Figure 3C, 3D) while neither mES nor a mouse parietal
endodermal cell line had detectable levels of K19 protein. K19
expression is detectable in trophoblast stem cells and increases
upon differentiation in culture (data not shown). These results
were confirmed with several additional antibodies that were
species specific for either mouse or human keratins. While hES
cells express significant levels of K8, K18 and K19, human Caco2
colon carcinoma cells and MCF7 breast cancer cells (Figure 3B,
3D, lanes 7 and 8) express 3–20 fold higher levels of these proteins.
Figure 1. Keratin RNA expression in mouse ES cells and EpiSCs. A, time course of K8, K18 and K19 RNA induction in mouse ES cells during
embryoid body differentiation plotted from supplementary data of a published report [33]. Data set is identified by the GSE number of the GEO data
base. B, contrasting expression of K8, K18 and K19 in mouse ES and epiblast stem cells (EpiSC). RNA expression data [10] for the indicated genes was
compared by normalizing the values of the two cell types to the corresponding signals for beta-actin RNA. Note the elevated expression of K8 (346)
and K18 (266) in EpiSC while RNAs for Nanog, Sox2 and Oct4 are similar in the two cell types. C, coordinate variation of K8 and K18 RNAs in individual
array values of ES and EpiSC samples from GSE7902. D, strong correlation between K18 and Jun RNA levels. Jun is a component of the AP-1
transcription factor activity previously identified as important in the induction of K18 RNA in differentiation mouse ES cells.
doi:10.1371/journal.pone.0003451.g001
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regard to expression of K8, K18 and K19 RNA and protein. With
mES cells, this work confirms previous studies of mES and mEC
cells [2,12,13,20].
Human ES cell keratin filaments
Both mouse and human ES cultures commonly develop variable
numbers of spontaneously differentiated, fibroblast-like and
extraembryonic endodermal cells. Immunofluorescent staining of
human ES cells was performed to confirm that keratin expression
was due to ES stem cells and not the differentiated progeny.
Figure 4 shows typical results of K8, K18 and K19 localization in
hES cells. At low magnification, a colony of hES cells grown with
mouse fibroblast feeder cells is relatively uniformly reactive with
antibodies to both Oct4 and K19 (Figure 4A,B). The mouse feeder
cells do not react with either Oct4 or K19 antibodies (Figure 4A).
Human ES cells express both K18 (Figure 4C) and K19
(Figure 4A,C) as type I keratin filament proteins. K8 is the
primary complementary type II keratin expressed in these
epithelial cells (Figure 4D). Similar results were obtained for the
H9, H14 and Hues7 human ES cell lines (Figure 4F) and in the
presence or absence of feeder layers.
Keratin changes associated with the differentiation of
hES cells
Spontaneous differentiation of both human and mouse ES cells
occurs commonly, even under conditions promoting ES cell self
renewal. Large differentiated cells typically found at the borders of
ES cell colonies had increased levels of K8, K18 (Figure 4E) and
K19 (Figure 4A). Human ES cells, unlike mES cells, spontaneously
differentiate to trophoblast lineage cells. K7 has been found to be a
useful marker of human trophoblast lineage [21]. While K7
positive cells are relatively rare in hES cultures they can be
detected as discrete colonies of presumptive trophoblast derivatives
within undifferentiated hES cell neighbors in cultures incubated
for a week or longer. In freshly passaged cells K7 positive cells
were detected as dispersed single cells, apparently due to the
dissociation of rare colonies of presumptive trophoblasts.
(Figure 5A, B). Supporting evidence that the K7 expression
reflects trophoblast formation is provided by the correlation of K7
RNA with the CDX2 homeobox master regulatory transcription
factor (Figure 5C) in a data set that includes both undifferentiated
and differentiated hES cells [17]. Furthermore the expression of
CDX2 RNA was inversely correlated with OCT4 RNA
(Figure 5D), as expected from the known repression of CDX2
by OCT4 [22,23].
Simple epithelia keratins are expressed only in the ependymal
layer of the ventricles of the adult brain. The differentiation of hES
to neural tissues can now be performed routinely. We have
confirmed that during the accelerated differentiation of hES cells
to neuronal progenitor cells expression of K8 and K18 are
decreased (Figure 6A). The K8 and K18 RNAs appear
coordinately suppressed (Figure 6B). However, this suppression is
not due to decreased Jun RNA expression as there is no
correlation of K18 and Jun RNAs (data not shown). Repression
is correlated with increased expression of Snai2 (Slug) a
transcriptional repressor associated with neural crest formation
and epithelial-mesenchymal transition (Figure 6C). Snai2 has
previously been suggested as active in K8 repression [24]. Unlike
Figure 2. Keratin RNA expression in hES cells. A, published results of hES cells and embryoid body cultures [17]. Data was downloaded from
http://www.stemcellcommunity.org/. Averages and standard deviations of normalized data of six undifferentiated cell cultures (WA09, BG01, BG02,
BG03) and three embryoid body (EB) cultures (BG01, BG02, BG03). Keratin RNA expression in EBs was less than 26greater than stem cultures. B,
coordinate levels of K8 and K18 RNAs. Values for single arrays of different conditions are compared. C, coordinate values of K8 and K19 RNAs. D,
correlation of K18 RNA values with Jun RNA, a key transcriptional regulator of the K18 gene.
doi:10.1371/journal.pone.0003451.g002
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trend upon the induction of neuronal progenitor differentiation
(Figure 6D). Thus the mechanisms for suppression of K8 and K18
RNAs do not appear to extend to K19 regulation.
Discussion
Some investigations of the hES cells have reported unexpected
expression of K8 and K18 because these gene products were
expected to be differentiation markers. [9]. Some of these early
studies suggested that expression might be due to contamination
from differentiated cells or possibly translational regulation.
However, a meta analysis of the results of over 38 studies of gene
expression in hES cells confirms that K8 and K18 RNAs are
commonly found in undifferentiated hES cells [19] and are
generally increased in differentiated cells from embryoid bodies.
We have confirmed that undifferentiated hES cells express simple
Figure 3. Keratin protein expression in hES cells. Western blots
for K8 and K18 were performed with antibodies that recognize both the
mouse and human forms of K8 (TROMA1) [6] and K18 (1589) [40].
Antibody reactions were detected and quantitated with Infrared dye
labeled secondary antibodies and the LI-COR Odyssey imaging system.
A, keratin protein signals were divided by the corresponding tubulin
signals. K8 and K18 normalized values were set to 100% for mEndo cells.
B, digital image of secondary antibody reaction; MEF (1), mouse
embryonic fibroblast; csk (2), non-ionic detergent insoluble fraction of
mEndo cells; mEndo (3), the HR9 mouse extraembryonic endodermal
cells (4) [43]; Human ES cell lines (5,6); CaCo (7), human colon carcinoma
cell line; MCF7 (8), human breast cancer cell line. The upper two panels
are from one filter and the bottom two panels are from a second
Figure 4. Immunofluorescent detection of K8, K18 nd K19 in
hES cells. A, low magnification of H9 hES cells surrounded by MEF
feeder layer double stained for Oct4 (red) and K19 (green). Feeders do
not react with either antibody. B, high magnification of colony shown in
A, showing single Oct4 positive ES cells contain K19 positive filaments.
C, low magnification of H14 hES cell colony grown on Matrigel without
feeders and stained for K18. D, high magnification of H14 hES cells
showing K8 network. Nuclei are stained with DAPI (blue). E,
spontaneous differentiated cells at edge of H14 hES colony have
increased size and K18 expression. F, example of K8 staining of Hues7
hES cell line.
doi:10.1371/journal.pone.0003451.g004
duplicate filter. C, ratio of K19 signal to tubulin signal after background
subtraction. D, K19 protein expression in hES cells. Western blot
reaction with the L2PK mouse monoclonal antibody to K19 [41,42].
Tubulin was detected after stripping the K19 antibody. Lanes 1–8 are
defined as above.
doi:10.1371/journal.pone.0003451.g003
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other simple epithelial cells, and by contrast with mouse ES cells.
The differences in K8 and K18 expression in mouse and hES
cells may reflect a fundamental difference between the embryonic
equivalent of the mouse and human inner cell masses. The human
epiblast is an epithelial structure while the mouse ICM does not
adopt an epithelial organization until after blastocyst implantation.
Keratin expression in hES cell lines reflects the more flattened
epithelial phenotype of hES colonies compared to mouse ES cells.
The expression of keratins may reflect differences in the
originating cell types of the respective blastocysts or differences
in the the state of acquisition of a stable, self-replicative capacity.
The suppression of K8 and K18 expression in the mouse inner cell
mass is an active process that may correspond to the transcrip-
tional inhibitory activity detected in embryonal carcinoma cells
[13]. The increased expression of K8 and K18 in mouse epiblast
stem cells (EpiSC) is consistent with the suggestion that both ES
and EpiSC cells lines reflect the characteristics of the embryonic
tissue of origin. In transplantation experiments human specific K8,
K18 or K19 antibodies may aid in identifying both hES cells and
their differentiated progeny.
Mouse EpiSC are poorly compatible with embryo chimerism, at
least by standard ES cell methods of blastocyst injection and
morula aggregation, but retain the ability to differentiate to
multiple tissues as judged by teratoma formation and in vitro
differentiation [10,11]. The strong intercellular adhesive and
epithelial nature of EpiSC and hES cells may challenge the
integration of EpiSC into preimplantation embryos. Thus ES cells
are preferable for gene knockout studies. Mouse EpiSC do provide
the opportunity of investigating maintenance of the pluripotent
state and perhaps model hES cells. Speculative extrapolation of
the similarity between hES cells and mouse EpiSC might question
the compatibility of hES cells with early embryonic chimerism.
Differences in expression of simple epithelial keratins in mouse
and human ES cells may also have direct consequences on hES
cells. These keratins have been implicated in resistance against
death receptor mediated apoptosis [25,26,27] and stress, possibly
through the titration of phospho-protein signaling molecules
[26,28]. Phosphorylated K8/18 networks can titrate phospho-
protein binding proteins such as 14-3-3 isoforms and thus impact
Figure 5. Presumptive trophoblast differentiation of H9, hES
cells. A, K7 positive colony of cells forming within a H14 hES cell
colony. Nuclei are stained with DAPI (blue). B, higher magnification
showing extended cytoskeletal pattern of K7 with increased densities at
intercellular borders. C, K7 RNA expression is correlated with Cdx2 RNA
expression in hES cell cultures [17]. Cdx2 is a master regulator of
trophoblast differentiation. D, Cdx2 RNA is inversely correlated with
Oct4 RNA expression in differentiating cultures of hES cells.
doi:10.1371/journal.pone.0003451.g005
Figure 6. Decreased keratin expression during neuronal
differentiation. Averages o fat least two samples for each time point
were used to measure K7, K8, K18 and K19 RNAs as a function of hours
after starting induction of neuronal progenitor differentiation. A, K7, K8
and K18 RNA levels over time course of 240 hours. Trendline is for K18
data. B, correlation of K8 and K18 RNA levels during neuronal
progenitor differentiation. C, negative correlation of K18 RNA and
Snai2 RNA levels. D, K19 RNA levels do not reveal a simple trend.
doi:10.1371/journal.pone.0003451.g006
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insoluble subunits of simple epithelial keratins carries the risk of
protein aggregation induced cellular disease [30]in the event of
mutation, imbalance of subunit expression, chemical induced
aggregation or deficient degradation [31].
While expression of keratins in hES cells is substantial,
accumulated expression in some cells can be much higher. For
example in the MCF7 human breast cancer cell line, K18 is
among the most abundant proteins within the cells. Similarly,
spontaneous differentiated cells arising in hES cultures contain
substantially higher accumulation of keratin proteins. The stability
and abundance of individual keratins makes them excellent cell
type or lineage markers. However, the molecular mechanisms
responsible for the cell type specific expression are still obscure.
The very close correspondence of RNA levels of K8 and K18 very
likely reflect their coordinate regulation from adjacent locations at
the distal end of the type II keratin locus on chromosome 12. Both
genes are regulated by AP-1 and Ets transcription factor families
[14,32]. Jun activates the K18 gene from an enhancer located in
the first intron and from a regulatory element embedded within a
coding exon [33]. The coordinate regulation of K8 and K18 may
reflect the recent identification of CTCF insulator protein binding
sites flanking the two genes on chromosome 12 [34] that suggests a
chromosomal regulatory domain. In contrast, the coordinate
expression of the K8 and K19 genes occurs despite the separate
chromosomal locations of K8 on chromosome 12 and K19 on
chromosome 17. The basis of coordinate regulation of pairs of
type I and II keratins is not known.
Materials and Methods
RNA expression analysis
Primary RNA expression data from mouse ES cells [35] (Agilent
platform, GSE3231), human ES cells [17] (Illumina platform),
(www.stemcellcommunity.org) and mouse EpiSC and ES cells
(Agilent platform, GSE7902) [10] were downloaded and examined
for keratin gene expression in Excel. For some comparisons of
different cell types, keratin expression was normalized to signals of
same arrays for beta-actin although this normalization did not
change the results greatly. Confirmation of hES cell expression of
keratins wasconfirmed inarrayresults availablethroughAmazonia!
public database [19] (http://amazonia.montp.inserm.fr/).
Differentiating human ES cells RNAs were isolated with the use
of Trizol reagent (Sigma Chemical, St. Louis, Mo). Labeled cRNA
was prepared from 500 ng RNA using the IlluminaH RNA
Amplification Kit from Ambion (Austin, TX, USA). The Biotin
labeled cRNA (750 ng) was hybridized 18 hr at 58uC to the
HumanRef-8 v2 Expression BeadChip. (Illumina, San Diego, CA,
USA) according to the manufacturer’s instructions. BeadChips
were scanned with an Illumina BeadArray Reader and hybrid-
ization efficiency was monitored using BeadStudio software
(Illumina) and internal controls built into the Illumina system.
Gene expression data was imported into Genespring software.
Cell culture
Human ES cell lines H9 and H14, were cultivated on
inactivated mouse fibroblast feeder layers or on growth factor
reduced Matrigel coated plastic in Knockout DMEM (Invitrogen)
supplemented with 200 mM glutamine, 0.1 mM 2-mercaptoeth-
anol [36] 20% Knockout serum substitute (Invitrogen) and 25 ng/
ml recombinant human basic FGF (Sigma, St. Louis, MO) as
described [37,38]. Hues7 and Hues13 cells were propagated as
described [39]. D9 mouse ES cells, HR9 mouse extraembryonic
endodermal cells and mouse trophoblast stem cells were cultivated
as previously described [3,40,41]. MCF7 and CaCo2 human
tumor cells were obtained from ATCC.
Methods and characterization of accelerated hES cell differen-
tiation to neural progenitors, will be described in detail elsewhere
(Bajai, R and Terskikh, A, submitted). In short, small clusters (10–
100 cells) of hESCs were grown in uncoated dishes (Costar) in 1:1
ratio of DMEM/ and F12 medium with N2 (Gibco) and B27
(Gibco) factor supplements, 20 ng/ml insulin 20 ng/ml bFGF,
20 ng/ml EGF and 2 mM N-acetyl cysteine (NAC)). The spheres
were grown for 6–8 days, with a change in medium every alternate
day. Spheres were collected, gently triturated and plated on
ornithine coated (5 ng/ml, Sigma) plates in DMEM/F12, 10%
BIT 9500 supplement (Stem Cell Technologies, ), 20 ng/ml
bFGF, 20 ng/ml EGF, 5 ug/ml fibronectin, 2 ug/ml heparin).
Protein analysis
For western blot analysis of total keratin proteins, 6 cm dishes of
PBS washed cells were dissolved in 200 ul of 9.5 M urea, heated to
100c for 5 min, mixed vigorously and cleared of minimal residual
debris by centrifugation. Samples were dilute with concentrated
SDS sample buffer and separated in low bis acrylamide gels as
previously described [3]. Proteins were blotted onto PVDF
membranes according to the instructions of the supplier of the
secondary antibodies (Li-COR Bioscience) and detected with 680
or 800 CW IR-dye labeled secondary antibodies. Reaction was
imaged and quantitated in a LI-COR Odyssey image analyzer.
Filters were stripped in 62.5 mM TrisHCL, pH 6.8, 2% SDS,
100 mM 2-mercaptoethanol at 55C for 1 hour and re-probed with
antibody to beta-tubulin (E7 mouse monoclonal antibody,
(Developmental Studies Hydridoma Bank, Iowa City, Iowa).
Results are shown for antibodies that detected both human and
mouse form of rat monoclonal antibody to K8 (TROMA1) [6] (gift
from Rolf Kemler, available from Developmental Studies
Hydridoma Bank); rabbit polyclonal antiserum to mouse K18
(1589) [42] and mouse monoclonal antibody to K19 (L2PK)
[43,44] (gift from Dr. Birgit Lane) are shown. Results were also
confirmed with the following antibodies that were species
dependent: mouse monoclonal to K8, M20 (Sigma); rat mono-
clonal to mouse K18, TROMA2 [6], mouse monoclonal to
human K18, CK5 (Sigma); mouse monoclonal to human K19,
K4.62 (Sigma).
Immunofluorescence
Cells were plated on feeder layer or Matrigel coated glass
coverslips, fixed in cold methanol for 10 minutes, rinsed and
incubated with PBS-T (PBS
Ca+/Mg++0.1% Tween20) for one hour
at room temperature. Cells were blocked for 20 minutes in PBS
supplemented with 2% goat serum (Gibco). For combined
detection of Oct3/4 and K19, Oct3/4 antibody (H-134, sc-9081
rabbit polyclonal from Santa Cruz) was diluted 1:250 in 1% goat
serum (GS) in PBS and incubated with the cells overnight at 4uC.
Cells were washed with PBS-T and PBS. The second primary
antibody (K19, LP2K monoclonal cell culture supernatant) was
used neat for one hour at room temperature. After washing,
secondary antibodies against the species were combined and
diluted 1:500 in 1% GS-PBS (Alexa 488 anti-mouse and Alexa
546 anti-rabbit from Invitrogen). Cells were incubated with the
secondary antibodies for one hour at room temperature in the
dark. Washes were repeated as described above. Finally cells were
incubated with a DAPI solution for 3 minutes followed by two
PBS washes. Other keratins were detected by incubating with
either TROMA1 (rat antiK8), M20 (mouse antiK8, 1:200), 1589
(rabbit polyclonal antiK18, 1:40), RCK105 (mouse monoclonal
antiK7, 1:2, gift from F. Ramaekers) and the appropriate
Keratins in hES Cells
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procedures. Images were acquired on an inverted TE300 Nikon
or an OlympusIX71 fluorescence microscope with a Diagnostic
Instrument cooled color CCD SPOT RT camera or Hamamatsu
Digital Camera respectively. Images were combined in either
SPOT or MetaVue 7.1.6.0 software and were formatted for
publication with Photoshop software.
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